Delivery Order SPE2DB24D1007-SPE2DB25FCCWT
- Not listed
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,061.58 firm fixed price delivery order is for the supply of 4,564,085,587 units of the prescription medication Xtampza ER 27 mg capsules. The contract has a period of performance through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,804.59 to AmerisourceBergen Drug Corp on August 12, 2025, for Xtampza ER Caps 27mg, a controlled-release opioid medication. This firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- This is a $3,534.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xtampza ER 36 mg capsules, a prescription pain medication, with a period of performance through June 2025. The award is not set aside and was made through open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,290.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 9 mg capsules (100-count units) with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- The Defense Logistics Agency awarded a delivery order valued at $1,538.92 to AmerisourceBergen Drug Corp for XTAMPZA ER 36 mg capsules (100 count), with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete openly for federal medical procurement requirements....
- The Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $4,605.69 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product, to be completed by February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
- This is a $2,239.69 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xtampza ER 9 mg capsules. The contract has a completion date of July 30, 2024 and was awarded on July 29, 2024. The contract is not set aside for any specific business designation. As a key supplier to federal healthcare programs, AmerisourceBergen leverages its extensive pharmaceutical supply chain to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XTAMPZA ER CAPS 36MG. The award has a ceiling value of $5,229.60 and an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCWTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,341.70 to AmerisourceBergen Drug Corp for the supply of Xtampza ER 13.5 mg capsules (100 count) on August 18, 2025, with completion targeted for August 19, 2025. The award is structured as a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen Drug Corp's corporate headquarters. This delivery order is issued under a larger indefinite delivery vehicle—the DLA Troop Support Medical contract (SPE2DX)—valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company holds significant capacity across the Defense Health Agency's pharmaceutical supply chain, delivering a comprehensive range of medications and medical supplies to support military healthcare programs globally. This specific delivery order for Xtampza, an extended-release pain management medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs within the federal medical supply network. The contract represents one of many competitive awards the company receives through the DLA's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/18/25 |